Trilogy System News Today

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 6, 2024--

The global Single Dose Radiotherapy Services Market is estimated to attain a valuation of US$ 7.88 billion in 2023 and is expected to reach US$ 16 billion by 2033. The market is expected to rise at a CAGR of 7.3% throughout the forecast period.The market’s expansion is propelled by several factors, including the inc...

FinancialContent fully hosted finance channel

IRVINE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve...

JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace

IRVINE, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve...

JenaValve announced today that it successfully completed patient enrollment in a trial evaluating its Trilogy heart valve system.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

JenaValve Technology Receives CE Mark for its Trilogy™ TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis May 25, 2021 08:00 ET | Source: JenaValve Technology, Inc. JenaValve Technology, Inc. Irvine, California, UNITED STATES IRVINE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation (TAVI) systems (also referred to as TAV...

IRVINE, Calif., May 25, 2021 — JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation (TAVI) systems (also referred to as TAVR, or transcatheter aortic valve replacement) for the treatment of aortic valve disease, today announced that it has received CE Mark for its Trilogy™ Heart Valve System for the treatment of both aortic regurgitation (AR), also known as aortic insufficiency (AI), and aortic stenosis (AS).